Cheol-Kyu Park

发表

Respiratory Review of 2014: Tuberculosis and Nontuberculous Mycobacterial Pulmonary Disease

Yong-Soo Kwon, Cheol-Kyu Park, 2014, Tuberculosis and respiratory diseases.

First-line Afatinib in Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in South Korea

Y. Chang, Shin‐Yup Lee, Chang-Min Choi, 2022, AntiCancer Research.

Microbiological Characteristics and Predictive Factors for Mortality in Pleural Infection: A Single-Center Cohort Study in Korea

Youngchul Kim, I. Oh, Yong-Soo Kwon, 2016, PLoS ONE.

Predictors of Default from Treatment for Tuberculosis: a Single Center Case–Control Study in Korea

Yong-Soo Kwon, Cheol-Kyu Park, S. Lim, 2016, Journal of Korean medical science.

Different characteristics associated with intensive care unit transfer from the medical ward between patients with acute exacerbations of chronic obstructive pulmonary disease with and without pneumonia.

Youngchul Kim, I. Oh, Yong-Soo Kwon, 2016, Journal of thoracic disease.

Randomized Phase III Study of Docetaxel Plus Cisplatin Versus Pemetrexed Plus Cisplatin as First‐line Treatment of Nonsquamous Non–Small‐cell Lung Cancer: A TRAIL Trial

Youngchul Kim, I. Oh, S. Jang, 2017, Clinical lung cancer.

What is Currently the Best for Adenocarcinoma without Driver Mutation?

I. Oh, Cheol-Kyu Park, Young Chul Kim, 2018, Tuberculosis and respiratory diseases.

Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG)

Sung Sook Lee, J. Shih, T. Hsia, 2022, The oncologist.

Quantification of epidermal growth factor receptor (EGFR) mutation may be a predictor of EGFR‐tyrosine kinase inhibitor treatment response

Youngchul Kim, I. Oh, Yong-Soo Kwon, 2016, Thoracic cancer.

Glutathione Peroxidase 3 as a Biomarker of Recurrence after Lung Cancer Surgery

Youngchul Kim, I. Oh, J. Yun, 2019, Journal of clinical medicine.

Sequential Treatment of Afatinib and Osimertinib in Patients with Advanced Non-small Cell Lung Cancer Harboring EGFR Mutations: Results from a Real-world Study in South Korea

Mi Hyun Kim, Y. Chang, Shin‐Yup Lee, 2021 .

Clinical factors associated with weaning failure in patients requiring prolonged mechanical ventilation.

Youngchul Kim, I. Oh, Yong-Soo Kwon, 2017, Journal of thoracic disease.

Delayed diagnosis of lung cancer due to misdiagnosis as worsening of sarcoidosis: a case report

I. Oh, Cheol-Kyu Park, S. Lim, 2020, BMC Pulmonary Medicine.

Vitiligo-like depigmentation after pembrolizumab treatment in patients with non-small cell lung cancer: a case report

I. Oh, H. Kim, K. Na, 2020, Translational lung cancer research.

Myasthenia gravis and myopathy after nivolumab treatment for non‐small cell lung carcinoma: A case report

I. Oh, T. Nam, Cheol-Kyu Park, 2019, Thoracic cancer.

Real-world Outcomes of First-line Afatinib in Patients with Non-small Cell Lung Cancer and Uncommon EGFR Mutations in South Korea

Mi Hyun Kim, Y. Chang, Shin‐Yup Lee, 2021 .

Efficacy of Afatinib in a Previously-Treated Patient with Non-Small Cell Lung Cancer Harboring HER2 Mutation: Case Report

I. Oh, Chang-Min Choi, Tae Ok Kim, 2017, Journal of Korean medical science.

Acute respiratory distress syndrome and chemical burns after exposure to chlorine-containing bleach: a case report.

I. Oh, Yong-Soo Kwon, Cheol-Kyu Park, 2017, Journal of thoracic disease.

Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation–Positive Non–Small Cell Lung Cancer

Jae Cheol Lee, Shin‐Yup Lee, S. Jang, 2022, Cancer research and treatment.

Efficacy of immune checkpoint inhibitors according to PD‐L1 tumor proportion scores in non‐small cell lung cancer

I. Oh, Cheol-Kyu Park, Y. Choi, 2019, Thoracic cancer.

Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors

E. Shin, I. Oh, Jeong Eun Lee, 2020, Immune network.

Progastrin-releasing peptide as a diagnostic and therapeutic biomarker of small cell lung cancer.

I. Oh, S. Kim, M. Shin, 2016, Journal of thoracic disease.

Is transformed small cell lung cancer (SCLC) different from de novo SCLC?

I. Oh, Cheol-Kyu Park, Young-chul Kim, 2019, Translational cancer research.

Phase II open‐label multicenter study to assess the antitumor activity of afatinib in lung cancer patients with activating epidermal growth factor receptor mutation from circulating tumor DNA: Liquid‐Lung‐A

Jae Cheol Lee, Shin‐Yup Lee, I. Oh, 2020, Thoracic cancer.

Clinical Characteristics of Korean Patients with Lung Cancer Who Have Programmed Death-Ligand 1 Expression

I. Oh, Tae Ok Kim, Yong-Soo Kwon, 2019, Tuberculosis and respiratory diseases.

A Prospective Observational Study Evaluating the Correlation of c-MET Expression and EGFR Gene Mutation with Response to Erlotinib as Second-Line Treatment for Patients with Advanced/Metastatic Non-Small-Cell Lung Cancer

Shin‐Yup Lee, I. Oh, J. Ryu, 2018, Oncology.

Collaborative Care to Relieve Psychological Distress in Patients with Medically Inoperable Lung Cancer: Design and Rationale for a Clinical Trial

Sung-Wan Kim, I. Oh, Jae-Min Kim, 2019, Psychiatry investigation.

Belotecan/cisplatin versus etoposide/cisplatin in previously untreated patients with extensive-stage small cell lung carcinoma: a multi-center randomized phase III trial

I. Oh, Kyu-Sik Kim, K. Shin, 2016, BMC Cancer.

A Propensity-Matched Retrospective Comparative Study with Historical Control to Determine the Real-World Effectiveness of Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer

I. Oh, Cheol-Kyu Park, S. Ahn, 2023, Cancers.

Blood-Based Biomarker Analysis for Predicting Efficacy of Chemoradiotherapy and Durvalumab in Patients with Unresectable Stage III Non-Small Cell Lung Cancer

I. Oh, Cheol-Kyu Park, S. Ahn, 2023, Cancers.

Comprehensive analysis of blood-based biomarkers for predicting immunotherapy benefits in patients with advanced non-small cell lung cancer

I. Oh, Hyun-Ju Cho, Ji-Young Lee, 2021, Translational lung cancer research.

Efficacy and dose of afatinib in patients with non‐small cell lung cancer after failure of prior gefitinib or erlotinib treatment

I. Oh, Hayoung Choi, Cheol-Kyu Park, 2021, Thoracic cancer.

Treatment outcomes and safety of afatinib in advanced squamous cell lung cancer progressed after platinum‐based doublet chemotherapy and immunotherapy (SPACE study)

Chang-Min Choi, Cheol-Kyu Park, Sung-Yong Lee, 2021, Thoracic cancer.

A Phase II Trial of Osimertinib as the First-Line Treatment of Non–Small Cell Lung Cancer Harboring Activating EGFR Mutations in Circulating Tumor DNA: LiquidLung-O-Cohort 1

I. Oh, Hyun-Ju Cho, Cheol-Kyu Park, 2020, Cancer research and treatment : official journal of Korean Cancer Association.

Feasibility of liquid biopsy using plasma and platelets for detection of anaplastic lymphoma kinase rearrangements in non-small cell lung cancer

I. Oh, Cheol-Kyu Park, Hong-Joon Shin, 2019, Journal of Cancer Research and Clinical Oncology.

Predictive factors for long‐term responders of pemetrexed maintenance treatment in non‐small cell lung cancer

I. Oh, Cheol-Kyu Park, Y. Choi, 2019, Thoracic cancer.

A Phase II Trial of Osimertinib in the Second-Line Treatment of Non-small Cell Lung Cancer with the EGFR T790M Mutation, Detected from Circulating Tumor DNA: LiquidLung-O-Cohort 2

I. Oh, Hyun-Ju Cho, Cheol-Kyu Park, 2018, Cancer research and treatment : official journal of Korean Cancer Association.

Clinically beneficial continued treatment with gefitinib after asymptomatic progression of lung adenocarcinoma

I. Oh, Kyu-Sik Kim, Hayoung Choi, 2015, Thoracic cancer.

Peptide Nucleic Acid Clamping Versus Direct Sequencing for the Detection of EGFR Gene Mutation in Patients with Non-small Cell Lung Cancer

I. Oh, Kyu-Sik Kim, Hayoung Choi, 2015, Cancer research and treatment : official journal of Korean Cancer Association.

Risk factors for primary lung cancer among never-smoking women in South Korea: a retrospective nationwide population-based cohort study

Sung Ho Hwang, Chan Kwon Park, W. Kim, 2020, The Korean journal of internal medicine.

Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non‐small‐cell lung cancer harboring EGFR mutations: Results from a real‐world study in South Korea

Y. Chang, Shin‐Yup Lee, Chang-Min Choi, 2021, Cancer medicine.

Artificial intelligence and lung cancer treatment decision: agreement with recommendation of multidisciplinary tumor board

Y. Kim, Sae-Ryung Kang, I. Oh, 2020, Translational lung cancer research.

Belotecan/cisplatin versus etoposide/cisplatin in previously untreated patients with extensive-stage small cell lung carcinoma: a multi-center randomized phase III trial

I. Oh, Kyu-Sik Kim, K. Shin, 2016, BMC Cancer.

Endobronchial amyloidosis mimicking bronchial asthma: a case report and review of the literature

I. Oh, Yong-Soo Kwon, Cheol-Kyu Park, 2016, Open medicine.

Pulmonary sclerosing pneumocytoma mimicking lung cancer: Case report and review of the literature

I. Oh, J. Yun, Sang‐Yun Song, 2016, Thoracic cancer.

Once-Daily OROS Hydromorphone for Management of Cancer Pain: an Open-Label, Multi-Center, Non-Interventional Study

I. Oh, K. Na, G. Song, 2016, Journal of Korean medical science.

Review of Sarcoidosis in a Province of South Korea from 1996 to 2014

I. Oh, Yong-Soo Kwon, Cheol-Kyu Park, 2017, Tuberculosis and respiratory diseases.

Clinical Activity of Pan‐HER Inhibitors Against HER2‐Mutant Lung Adenocarcinoma

Jae Cheol Lee, I. Oh, Chang-Min Choi, 2018, Clinical lung cancer.

Feasibility of re‐biopsy and EGFR mutation analysis in patients with non‐small cell lung cancer

Jung-Hwan Lim, Tae-Ok Kim, In-Jae Oh, 2018, Thoracic cancer.

Clinical Validation of a Protein Biomarker Panel for Non-Small Cell Lung Cancer

Woochang Lee, I. Oh, Chang-Min Choi, 2018, Journal of Korean medical science.

Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial

Jae Cheol Lee, Shin‐Yup Lee, I. Oh, 2023, Cells.

Efficacy and safety of docetaxel plus oxaliplatin as a first‐line chemotherapy in patients with advanced or metastatic non‐small cell lung cancer

I. Oh, Kyu-Sik Kim, Yong-Soo Kwon, 2014, Thoracic cancer.

Efficacy of Darbepoetin alfa in Anemia Developed during Chemotherapy for Lung Cancer

I. Oh, Yong-Soo Kwon, H. Ban, 2009 .

Awareness and Use of Complementary and Alternative Medicine in Korean Lung Cancer Patients

I. Oh, W. Ji, Chang-Min Choi, 2020, Tuberculosis and respiratory diseases.

Co-alteration of EGFR mutation and ALK rearrangement in non-small cell lung cancer

I. Oh, Cheol-Kyu Park, S. Lim, 2019, Medicine.

Efficacy of an inpatient smoking cessation program at a single regional cancer center

I. Oh, S. Kweon, Cheol-Kyu Park, 2021, Medicine.

Clinical characteristics and prognosis of patients with Pneumocystis jirovecii pneumonia without a compromised illness

I. Oh, Yong-Soo Kwon, Cheol-Kyu Park, 2021, PloS one.

Histological transformation from non-small cell to small cell lung carcinoma after treatment with epidermal growth factor receptor-tyrosine kinase inhibitor

I. Oh, Kyu-Sik Kim, Hayoung Choi, 2014, Thoracic cancer.

Is transformed small cell lung cancer (SCLC) different from de novo SCLC

I. Oh, Cheol-Kyu Park, Young-chul Kim, 2019 .

Healthcare utilization of lung cancer patients associated with exposure to fine particulate matter: A Korean cohort study

I. Oh, J. Min, S. Yang, 2023, Thoracic cancer.

Serum KL-6 levels predict the occurrence and severity of treatment-related interstitial lung disease in lung cancer

I. Oh, Cheol-Kyu Park, S. Lim, 2023, Scientific reports.

Role of adjuvant treatment in stage IB non-small cell lung carcinoma

I. Oh, Cheol-Kyu Park, Young-chul Kim, 2023, Translational lung cancer research.

Homeostatic Dysregulation of Systemic CD8+ T Cell Compartment in Lung Cancer Patients

Cheol-Kyu Park, Hee-Ok Kim, Sung-Woo Lee, 2023, bioRxiv.

Real-World Treatment Outcomes and Safety of Afatinib in Advanced Squamous Cell Lung Cancer Progressed after Platinum-Based Doublet Chemotherapy and Immunotherapy (SPACE Study)

W. Ji, Juwhan Choi, Cheol-Kyu Park, 2023, Cancers.

Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors

Mi Hyun Kim, Y. Chang, Shin‐Yup Lee, 2023, Translational lung cancer research.

Korean Real-world Data on Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Durvalumab after Chemoradiotherapy: PACIFIC-KR.

Jae Cheol Lee, Shin‐Yup Lee, I. Oh, 2023, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.